CD274 and non-small cell lung carcinoma: In a comparative analysis between responders and non-responders to PD-1/PD-L1 inhibitors, miR-320 family members, such as miR-320d, miR-320c, and miR-320b, were identified as potential biomarkers for predicting the efficacy of immunotherapy in advanced NSCLC.